Bionik Laboratories Corp.
BNKL
$0.0001
$0.000.00%
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -1.36M | -1.08M | -1.13M | -1.38M | -1.71M |
| Total Depreciation and Amortization | 19.60K | 19.90K | 12.40K | 11.30K | 12.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 292.40K | 61.70K | 72.50K | 55.70K | 351.00K |
| Change in Net Operating Assets | 287.40K | 481.90K | 89.20K | 154.70K | -38.60K |
| Cash from Operations | -756.90K | -512.80K | -955.30K | -1.16M | -1.38M |
| Capital Expenditure | -800.00 | -800.00 | -7.20K | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | -215.00K | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -800.00 | -800.00 | -222.20K | -- | 0.00 |
| Total Debt Issued | 500.00K | 800.00K | 250.00K | 500.00K | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | 1.40K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 500.00K | 800.00K | 250.00K | 500.00K | 1.40K |
| Foreign Exchange rate Adjustments | -100.00 | 1.00K | -3.60K | -300.00 | -200.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -257.80K | 287.50K | -931.00K | -662.60K | -1.38M |
